Search
Cannabis Legal & Business Issues for Employers & Employees There is no shortage of legal issues and regulations about which employers and employees must be aware. And with the introduction of state-legalized cannabis products for both medicinal and adult use, the legal landscape governing these...
Zachary Kobrin spoke on a panel titled, “Here Comes the Money: Banking and Payment Processing in the Cannabis Industry” at the 2023 Cannabis Law Institute, presented by the International Cannabis Bar Association (INCBA). The panel of experts will explore the current state of banking and payments in...
Zachary Kobrin spoke on a panel titled, “Representing Public Companies in Cannabis” at the NORML Denver Legal Seminar. The seminar will feature leading cannabis industry law firms in the country, lawyers who deal every day with the cutting edge issues faced by those working in the state-legal...
Partner Jonathan Havens will speak on "Cannabis and CBD in Food Products" at the Prime Label Consultants' Food Label Conference in Washington, D.C. Cannabidiol (CBD) remains in the news, especially since the U.S. Food and Drug Administration's January 26th announcement that existing regulatory...
CANNABIS LAW 2023: Protecting Intellectual Property in the Cannabis Industry As the cannabis industry grows and professionalizes, especially in the U.S., issues surrounding how to effectively protect intellectual property within the industry are coming to the fore with increased frequency. And in an...
While the cannabis industry as a whole continues to see significant growth, several forces have combined to make operating state-legal businesses more challenging. Cannabis businesses are facing a lack of access to affordable capital, increased cost of operations, and falling wholesale prices. With...
Live Wire? The Use of Workplace Impairment Recognition Experts and Other Methods to Determine Cannabis Impairment in the Workplace On April 21, 2022, New Jersey licensed dispensaries began sales of legalized adult-use Cannabis. Coupled with the longer-standing Medicinal Cannabis Program, New Jersey...
Partner Jonathan Havens will co-chair the 2023 FDLI Annual Conference. As the premier conference for the food and drug law community, the FDLI Annual Conference addresses complex legal, regulatory, compliance, and policy issues in all facets of the FDA-regulated industry. The conference provides in...
Zachary Kobrin spoke on a panel titled, “Private Equity Perspectives: A Look Into Investment Strategies for 2023 and Beyond” at the 3rd Annual Cannalaw Virtual Summit, presented by Inside Practice and the Cannalaw Network. Panelists discussed investment strategies, the importance of advisory...
Brave New World – Emerging Standards for Safety and Health in the Cannabis Industry Partners Jonathan Havens and Michael Metz-Topodas will be speaking during a CLE Webinar about emerging standards in the cannabis industry. Topics for Discussion include: Overview of the cannabis process and health...
Cannabis Basics: Getting up to Speed with Current Laws, Legislation, & Essential Business Issues The cannabis and hemp industries in the U.S. have exploded in recent years due to increased numbers of states allowing businesses to grow, process, and sell cannabis products for medical and adult use...
Breaking Into the Cannabis Market: Balancing the Profits Against the Risks of Non-Compliance In October 2022, the Biden Administration announced that it would begin pardoning all prior offences of simple possession of marijuana and asked that DEA and FDA begin the administrative process to review...
Adam Fayne will be moderating a panel at the Cannabis & Psychedelics Investment Summit in Miami, Florida on February 27, 2023. The panel topic will be Investment 101 for Family Offices: An Introduction to investing in cannabis and psychedelics.
Zachary Kobrin spoke on a panel titled, “Opportunities and Challenges in the 2023 Cannabis Market” presented by Centri Business Consulting. This webinar featured a panel of experts discussing trending financial topics in the cannabis industry including: Recent updates in Capital Markets & SAFE...
Work Product Protection for Patient Safety Information Charles Kelly, MS, partner, at Saul Ewing LLP, will walk attendees through two important pieces of legislation that protect healthcare workers: the Patient Safety and Quality Improvement Act of 2005, which ensures federal privilege and...
In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.
In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.
In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.
In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.
Saul Ewing is a proud sponsor of the Philadelphia Alliance for Capital and Technologies (PACT) Capital Conference. PACT’s mission is to provide content and connections to capital, coaching, and customers and to collaborate with other organizations to drive innovation and entrepreneurship in the...